In silico drug screen in mouse liver identifies candidate calorie restriction mimetics

Kristen Fortney1, Eric K Morgen, Max Kotlyar

  • 1Department of Medical Biophysics, University of Toronto, Ontario, Canada.

Rejuvenation Research
|April 27, 2012
PubMed

Insights

Calorie restriction (CR) extends lifespan and delays age-related diseases. Researchers identified 14 drugs that mimic CR's effects on gene expression, offering potential therapeutic benefits.

Area of Science:

  • Gerontology and Molecular Biology
  • Drug Discovery and Development

Background:

  • Calorie restriction (CR) is known to extend lifespan and mitigate age-related diseases like cancer and diabetes in mammals.
  • Understanding the molecular mechanisms of CR can reveal therapeutic targets for aging and disease.
  • Recent advances provide large-scale data on human cellular responses to drug treatments.

Purpose of the Study:

  • To identify potential drug candidates that mimic the life-extending and disease-delaying effects of calorie restriction.
  • To leverage genome-scale drug response data and CR gene expression signatures for drug discovery.

Main Methods:

  • Integration of genome-scale drug response data from human cell lines with gene expression signatures of CR in mouse liver.
  • Prioritization of candidate drugs based on their ability to replicate CR's transcriptional effects.

Main Results:

  • A prioritized list of 14 candidate drugs was generated.
  • These drugs were identified as potentially reproducing the effects of calorie restriction at the transcriptional level.

Conclusions:

  • The study successfully identified drugs that may act as CR mimetics.
  • These findings open avenues for developing therapeutics that target aging and related diseases by mimicking CR's molecular pathways.

Related Concept Videos